Find a Doctor

Locate a Doctor who fits your needs and your schedule.

Centers of Excellence

Lafayette General Health features two of Acadiana’s premier teaching hospitals, University Health & Clinics and Lafayette General Medical Center.
The Bariatric Surgery Department at Lafayette General Medical Center is accredited as a Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP).
Cancer Center of Acadiana spans across South Louisiana, bringing closer to home world renowned cancer treatments normally found at medical centers in Houston and New Orleans. The American College of Surgeons’ Commission on Cancer (CoC) granted a 3-year accreditation to CCA.
In June 2013, Lafayette General Medical Center (LGMC) was designated as a Center of Excellence in Minimally Invasive Gynecology (COEMIG) by the American Association of Gynecologic Laparoscopists and the Surgical Review Corporation.
After undergoing an on-site evaluation and demonstrating compliance with nationally developed standards for stroke care, Lafayette General Medical Center earned The Joint Commission's Gold Seal of Approval™ for certification as an Advanced Primary Stroke Center.
The neuroscience program at Lafayette General Medical Center (LGMC) attained Center of Excellence status in 2012 based on the results of a Neuroscience Center of Excellence® survey.
The orthopedics program was awarded The Joint Commission’s Gold Seal of Approval® receiving the Disease-Specific Care Certification for Joint Replacement Hip and Knee.

Acadia General, UHC Designated Level 2 WellSpot Locations

Hospitals implement nutrition programs and other initiatives to receive designation.


LGMC Receives 2015 Women’s Choice Award for Orthopedics

Lafayette General Medical Center (LGMC) is a recipient of the 2015 Women’s Choice Award® as one of America’s Best Hospitals for Orthopedics, providing exceptional patient care and treatment.


LGMC Conducting Clinical Trial on Myeloma

Cancer Center of Acadiana (CCA) at Lafayette General Medical Center is seeking men and women, ages 18 and older, diagnosed with multiple myeloma to participate in a clinical trial.

Open RSS feed

View All News »